1-3 of 3
Ann Marie Pendergast
Close
Sort by
Journal Articles

Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases

Robert C. Quackenbush, Gary W. Reuther, Juli P. Miller, Kevin D. Courtney, Warren S. Pear, Ann Marie Pendergast
Journal: Blood
Blood (2000) 95 (9): 2913–2921.
https://doi.org/10.1182/blood.V95.9.2913.009k32_2913_2921
Published: 2000
Journal Articles

The BCR/ABL Oncogene Alters the Chemotactic Response to Stromal-Derived Factor-1

Ravi Salgia, Elizabeth Quackenbush, Jeffrey Lin, Natalia Souchkova, Martin Sattler, Darren S. Ewaniuk, Kevin M. Klucher, George Q. Daley, Stine K. Kraeft, Robert Sackstein, Edwin P. Alyea, III, Ulrich H. von Andrian, Lan Bo Chen, Jose-Carlos Gutierrez-Ramos, Ann-Marie Pendergast, James D. Griffin
Journal: Blood
Blood (1999) 94 (12): 4233–4246.
https://doi.org/10.1182/blood.V94.12.4233
Published: 1999
Journal Articles

Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow

Warren S. Pear, Juli P. Miller, Lanwei Xu, John C. Pui, Benny Soffer, Robert C. Quackenbush, Ann Marie Pendergast, Roderick Bronson, Jon C. Aster, Martin L. Scott, David Baltimore
Journal: Blood
Blood (1998) 92 (10): 3780–3792.
https://doi.org/10.1182/blood.V92.10.3780
Published: 1998